STOCK TITAN

15,000-share MRK sale planned in Rule 144 notice (NYSE: MRK)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MRK had a Rule 144 notice filed for a planned sale of 15,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 1,827,991.50. The filing lists 2,482,022,536 shares of common stock outstanding.

The shares to be sold were acquired mainly through restricted stock vesting under a registered plan on multiple dates between May 2022 and January 2025, plus a small private acquisition from the issuer. The signer represents they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for MRK disclose?

The Form 144 discloses a planned sale of 15,000 MRK common shares on the NYSE with an aggregate market value of 1,827,991.50. It is a notice of intent to sell restricted or controlled securities under SEC Rule 144.

How many MRK shares are planned to be sold and on which exchange?

The filing covers a planned sale of 15,000 MRK common shares on the New York Stock Exchange (NYSE). These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, as listed in the broker information section.

What is the aggregate market value of the MRK shares in this Form 144?

The aggregate market value of the MRK common shares covered by this notice is 1,827,991.50. This value is based on the 15,000 shares indicated in the filing’s securities information table for the intended Rule 144 sale.

How were the MRK shares in the Form 144 acquired?

The shares were acquired primarily through restricted stock vesting under a registered plan on numerous dates between May 2022 and January 2025. The filing also lists a small private acquisition from the issuer on January 10, 2023.

What does the Form 144 say about MRK shares outstanding?

The securities information section states that there are 2,482,022,536 MRK common shares outstanding. This figure provides context for the size of the planned 15,000-share sale relative to the issuer’s total common stock base.

Which broker is handling the MRK Rule 144 share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is listed in the filing as the firm through which the 15,000 shares will be sold.
Merck & Co

NYSE:MRK

MRK Rankings

MRK Latest News

MRK Latest SEC Filings

MRK Stock Data

297.22B
2.48B
0.07%
80.59%
0.95%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
RAHWAY